was recently approved for market by China's National Medical Products Administration for the treatment of type 2 diabetes in adults. This innovative injection, which only needs to be administered ...

Liraglutide injections regulate blood sugar by mimicking the natural effects of GLP-1, a crucial hormone produced in the pancreas that is often insufficient in individuals with type 2 diabetes.